stars 1 stars 2 stars 3

OsteoGeneX is developing a first in class bone building small molecule against the validated target Sclerostin. OsteoGeneX possesses both near term accelerated clinical development opportunities, combined with proprietary approaches to developing first-in-class novel therapeutics.

OsteoGeneX, Inc Questions

5 people are employed at OsteoGeneX, Inc.

OsteoGeneX, Inc is based in Overland Park, Kansas.

Top OsteoGeneX, Inc Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users